Why are Immunovant shares$TRU $XAU $XAG
rising sharply today?
Immunovant shares rose 12.8% in morning trading after the Durham, North Carolina-based immunology company reported its fiscal second-quarter results before the market opened. The results significantly exceeded Wall Street expectations, while the company also disclosed positive Phase 2b data for its lead drug candidate. The company reported a loss of $0.41 per share for the quarter ended 30/09/2026, significantly beating analysts’ expectations of a loss of $0.74 per share, a positive surprise of $0.33 per share. Alongside its results, Immunovant announced that its 600 mg dose of IMVT-1402 met the primary endpoint in a potentially registrational clinical trial for hard-to-treat rheumatoid arthritis. The ACR20 response rate at week 28 was approximately 92.5%, compared with 75.6% for placebo, a statistically significant result.
#NvidiaInvestigatesAfterHuang’sAffairApology #CPITestsDecemberRateOutlook #CryptoLiquidationsReach$1.16BIn24Hours #CryptoLiquidationsReach$1.16BIn24Hours #ChinaCACListsFiveIssuesAffectingBlockchainFilings
rising sharply today?
Immunovant shares rose 12.8% in morning trading after the Durham, North Carolina-based immunology company reported its fiscal second-quarter results before the market opened. The results significantly exceeded Wall Street expectations, while the company also disclosed positive Phase 2b data for its lead drug candidate. The company reported a loss of $0.41 per share for the quarter ended 30/09/2026, significantly beating analysts’ expectations of a loss of $0.74 per share, a positive surprise of $0.33 per share. Alongside its results, Immunovant announced that its 600 mg dose of IMVT-1402 met the primary endpoint in a potentially registrational clinical trial for hard-to-treat rheumatoid arthritis. The ACR20 response rate at week 28 was approximately 92.5%, compared with 75.6% for placebo, a statistically significant result.
#NvidiaInvestigatesAfterHuang’sAffairApology #CPITestsDecemberRateOutlook #CryptoLiquidationsReach$1.16BIn24Hours #CryptoLiquidationsReach$1.16BIn24Hours #ChinaCACListsFiveIssuesAffectingBlockchainFilings
